4D Molecular Therapeutics (FDMT) closed at $12.29 on October 19, 2026, up 1.2% from the previous close, on volume of 810,252 shares (30-day average 918,291).
Data as of October 19, 2026.
19-Oct-2026
4DMT Announces New Employment Inducement Grants
Globe Newswire (Fri, 16-Oct 4:05 PM ET)
FDMT Sets October 21, 2026 Investor Day Spotlighting Phase 3 Retina Program 4D-150
Market Chameleon (Mon, 5-Oct 7:53 AM ET)
4DMT to Host Investor Day on October 21, 2026
Globe Newswire (Mon, 5-Oct 8:00 AM ET)
Globe Newswire (Mon, 28-Sep 8:00 AM ET)
4DMT to Participate in Upcoming Investor Conferences
Globe Newswire (Tue, 25-Aug 8:00 AM ET)
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
FDMT Secures $100 Million in Fresh Funding: New Offering Expands Clinical Ambitions
Market Chameleon (Thu, 6-Nov 3:05 AM ET)
Market Chameleon (Fri, 31-Oct 3:07 AM ET)
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
4D Molecular Therapeutics trades on the NASDAQ stock market under the symbol FDMT.
As of October 19, 2026, FDMT stock price climbed to $12.29 with 810,252 million shares trading.
FDMT has a beta of 1.18, meaning it tends to be more sensitive to market movements. FDMT has a correlation of 0.04 to the broad based SPY ETF.
FDMT has a market cap of $678.95 million. This is considered a Small Cap stock.
Last quarter 4D Molecular Therapeutics reported $4 million in Revenue and -$1.04 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.02.
In the last 3 years, FDMT traded as high as $36.25 and as low as $2.24.
The top ETF exchange traded funds that FDMT belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWN.
FDMT has outperformed the market in the last year with a return of +21.8%, while the SPY ETF gained +17.2%. In the last 3 month period, FDMT beat the market returning +13.4%, while SPY returned +2.4%. However, in the most recent 2 weeks FDMT has underperformed the stock market by returning -10.1%, while SPY returned -0.4%.
FDMT support price is $11.62 and resistance is $12.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FDMT shares will trade within this expected range on the day.
